Vertex Pharmaceuticals And BioMarin Pharmaceutical: 2 Safe Biotech Picks To Buy During This Bear Market [Seeking Alpha]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Seeking Alpha
The S&P 500 recovered by 7.03% on April 6, but the worst is far from over. Just a day before, the US surgeon general,Jerome AdamsAs the global economy continues to reel under the pressures of the escalating COVID-19 pandemic, biotech stocks focusing on other life-threatening conditions can offer refuge to shareholders. The companies should necessarily be profitable and also in no urgent need of external capital infusion. Vertex Pharmaceuticals (VRTXBMRNVertex has emerged as the darling of the biotech sector since November 2019 and not without reason. The stock is already up 16.60% YTD (year-to-date), while the S&P 500 is down by 17.55%. The company is the undisputed leader in CF (cystic fibrosis) segment. CF is a life-threatening genetic condition that results in the buildup of thick and sticky mucus in the lungs and obstruction of the pancreas. This condition has a global prevalence of around 75,000 patients.Previously, Vertex Pharmaceuticals hadthree FDA approved drugsOctober 2019Pr
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3Business Wire
- Crispr: Emphasis Shifts To Cardiovascular Pipeline Amid Slow Casgevy Launch [Seeking Alpha]Seeking Alpha
- Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $441.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
VRTX
Earnings
- 2/12/26 - Beat
VRTX
Sec Filings
- 2/19/26 - Form 4
- 2/19/26 - Form 4
- 2/19/26 - Form 4
- VRTX's page on the SEC website